Evidence map›Paper›PMID 41616251›Full record

ArticlePLoS biology2026

A gut-activated NHR-86-CYP pathway mediates the neuroprotective effects of Enterococcus faecium probiotics in a nematode model of amyotrophic lateral sclerosis.

Yu Sang, Jie Ren, Alejandro Aballay

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yu SangDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.ORCID 0000-0002-2981-1582
Jie RenDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Alejandro AballayDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.ORCID 0000-0002-5975-3352

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
C. elegans to study organismal control of recovery from bacterial infectionsR01AI117911 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ABALLAY, ALEJANDRO · 2016 to 2020
$1.9M
NIAID NIH HHS R01 AI117911NIH HHS P40 OD010440
6 · The paper itself

Abstract

Neurodegenerative diseases are often associated with oxidative stress, and while probiotics may influence neuronal health, the underlying mechanisms remain poorly understood. Using the sod-1 A4VM amyotrophic lateral sclerosis (ALS) model in Caenorhabditis elegans, we investigated the protective effects of the probiotic Enterococcus faecium against oxidative stress-induced neurodegeneration. Animals fed E. faecium showed reduced motor neuron degeneration under oxidative stress compared to those maintained on a standard Escherichia coli diet. Transcriptome analysis revealed a significant enrichment of oxidoreductase genes, including cytochrome P450 (cyp) genes. RNAi-mediated knockdown of cyp genes impaired E. faecium-mediated neuroprotection, and this loss correlated with increased reactive oxygen species (ROS) levels. We identified the conserved nuclear hormone receptor NHR-86 as a key regulator of cyp gene expression and neuroprotection. Loss of nhr-86 abolished the probiotic's protective benefits, while transgenic expression of nhr-86 restored cyp induction and neuronal resilience. Importantly, intestinal expression of NHR-86 was sufficient to restore CYP induction and neuronal resilience, whereas neuronal knockdown had no effect, indicating that gut NHR-86 activity is essential for this protective pathway. These findings reveal a previously uncharacterized NHR-CYP regulatory axis activated by an intestinal probiotic, highlighting a mechanistic link between microbial signals and host neuroprotection.

Indexed as

Amyotrophic Lateral SclerosisCaenorhabditis elegans ProteinsCytochrome P-450 Enzyme SystemEnterococcus faeciumNeuroprotective AgentsProbioticsAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansDisease Models, AnimalMotor NeuronsOxidative StressReactive Oxygen SpeciesSignal TransductionCaenorhabditis elegans ProteinsCytochrome P-450 Enzyme SystemNeuroprotective AgentsReactive Oxygen Species

Identifiers

PMID41616251
PMCPMC12872002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.